EMA Validates Gilead's Marketing Application for Sofosbuvir
Gilead Sciences, Inc. (GILD: Quote) said Tuesday that its Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European …
See all stories on this topic »
Malloy to address a tourism conference highlighting "Still Revolutionary" campaign
HARTFORD, Connecticut — Connecticut's “Still Revolutionary” tourism marketing campaign is succeeding and deserves continued funding, Gov. Dannel P. Malloy said Tuesday. The campaign, unveiled last year as part of a two-year, $27 million initiative, …
See all stories on this topic »
5 Reasons Why Network Marketing has a Bad Reputation. Is it …
If you've been alive long enough and have even a handful of friends, you've most likely been approached by someone building a network marketing or multi-lev.
See all stories on this topic »
